— Know what they know.
Not Investment Advice

ABSI NASDAQ

Absci Corporation
1W: -8.1% 1M: +38.3% 3M: +92.1% YTD: +41.0% 1Y: +82.4% 3Y: +335.0%
$5.10
+0.01 (+0.20%)
 
Weekly Expected Move ±16.9%
$3 $4 $5 $6 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 62 · $795.1M mcap · 133M float · 3.32% daily turnover · Short 44% of daily vol

Income Trends

Revenue
$3M -38.2% ▼
5Y CAGR: -10.1%
Gross Profit
-$9M +84.6% ▲
Operating Income
-$125M -14.5% ▼
Net Income
-$115M -11.7% ▼
EPS (Diluted)
$-0.84 +10.6% ▲
EBITDA
-$113M -20.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$5M$6M$6M$5M$3M
YoY Growth+0.0%+20.2%-0.5%-20.7%-38.2%
Cost of Revenue$45M$59M$48M$62M$12M
Gross Profit-$40M-$53M-$42M-$58M-$9M
Gross Margin-832.4%-925.0%-731.9%-1277.6%-319.4%
R&D Expenses$45M$59M$48M$64M$81M
SG&A Expenses$0$0$0$0$35M
Operating Expenses$35M$54M$74M$51M$116M
Operating Income-$75M-$107M-$116M-$109M-$125M
Operating Margin-1573.4%-1857.5%-2020.2%-2401.6%-4454.2%
Interest Expense$3M$972K$1M$565K$209K
Income Before Tax-$110M-$105M-$110M-$103M-$115M
Tax Expense-$9M-$461K$100K$70K$69K
Net Income-$101M-$105M-$111M-$103M-$115M
Net Margin-2111.3%-1825.4%-1933.6%-2274.1%-4113.7%
EPS (Diluted)$-1.11$-1.15$-1.20$-0.94$-0.84
EBITDA-$68M-$94M-$80M-$94M-$113M
Shares Outstanding93M91M92M110M137M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms